In glioma cell culture, additional administration of WNT5A, WNT3A and WNT1 promoted cell proliferation, which is in line with the clinical report that high expression of WNT5A, WNT3A and WNT1 correlated with short OS of patients with gliomas [27–29]. The gene discussed is WNT1; the disease is central nervous system cancer.